STOCK TITAN

Exyn Technologies, Inc. Form 4 Filings

EXYN NASDAQ

Every Form 4 that Exyn Technologies, Inc. (EXYN) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow EXYN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EXYN filings page.

Rhea-AI Summary

Exyn Technologies, Inc. director Gregory S. McNeal received a grant of stock options covering 23,200 shares of common stock on August 3, 2026. The options have an exercise price of $1.82 per share, expire on 2036-08-03, and vest one-third on August 3, 2027 and one-third on each one-year anniversary thereafter, contingent on continued service. Following the grant, he holds options on 23,200 shares.

Rhea-AI Summary

Exyn Technologies, Inc. reported that director and Chief Executive Officer Torres Declet Brandon received a grant of stock options on August 3, 2026 to purchase 109,000 shares of common stock at an exercise price of $1.82 per share. These options expire on August 3, 2036 and vest as follows: 25% of the shares vest on August 3, 2027 and the remaining shares vest in equal monthly installments, subject to Torres Declet Brandon continuing as a service provider through each vesting date. Following this award, the reporting person holds 109,000 stock options directly.

Rhea-AI Summary

Exyn Technologies, Inc. reported that director Tewksbury Ted L III received a grant of stock options covering 23,200 shares of common stock on August 3, 2026 at an exercise price of $1.82 per share.

The options vest one-third on August 3, 2027 and one-third on each one-year anniversary thereafter, expire on August 3, 2036, and result in direct holdings of 23,200 stock options.

Rhea-AI Summary

Exyn Technologies, Inc. director Ollwerther Jonathan Carey received a grant of stock options for 23,200 shares of common stock on August 3, 2026. The options have an exercise price of $1.82 per share, expire on August 3, 2036, and vest one-third on August 3, 2027 and one-third on each one-year anniversary thereafter, subject to continued service.

Rhea-AI Summary

Exyn Technologies, Inc. director Michael Burychka reported receiving a grant of stock options to purchase 23,200 shares of common stock on August 3, 2026, with an exercise price of $1.82 per share. The options vest in three equal annual installments starting August 3, 2027 and expire on August 3, 2036.